Compare GSK Pharma with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs AJANTA PHARMA - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA AJANTA PHARMA GSK PHARMA/
AJANTA PHARMA
 
P/E (TTM) x 53.3 27.6 192.8% View Chart
P/BV x 12.0 7.7 156.5% View Chart
Dividend Yield % 1.3 0.5 286.9%  

Financials

 GSK PHARMA   AJANTA PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
AJANTA PHARMA
Mar-19
GSK PHARMA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,5951,422 252.8%   
Low Rs1,253898 139.6%   
Sales per share (Unadj.) Rs184.7233.5 79.1%  
Earnings per share (Unadj.) Rs26.344.0 59.8%  
Cash flow per share (Unadj.) Rs29.252.2 55.9%  
Dividends per share (Unadj.) Rs20.009.00 222.2%  
Dividend yield (eoy) %0.80.8 106.3%  
Book value per share (Unadj.) Rs126.3255.1 49.5%  
Shares outstanding (eoy) m169.4088.02 192.5%   
Bonus / Rights / Conversions -BB-  
Price / Sales ratio x13.15.0 264.3%   
Avg P/E ratio x92.226.4 349.5%  
P/CF ratio (eoy) x83.122.2 373.8%  
Price / Book Value ratio x19.24.5 422.1%  
Dividend payout %76.120.5 371.6%   
Avg Mkt Cap Rs m410,626102,081 402.3%   
No. of employees `0005.06.8 72.9%   
Total wages/salary Rs m5,3724,307 124.7%   
Avg. sales/employee Rs Th6,306.73,022.6 208.7%   
Avg. wages/employee Rs Th1,083.1633.4 171.0%   
Avg. net profit/employee Rs Th898.0569.1 157.8%   
INCOME DATA
Net Sales Rs m31,28120,554 152.2%  
Other income Rs m1,023211 485.4%   
Total revenues Rs m32,30420,765 155.6%   
Gross profit Rs m6,0095,664 106.1%  
Depreciation Rs m486721 67.4%   
Interest Rs m612 51.7%   
Profit before tax Rs m6,5405,143 127.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,3731,273 186.4%   
Profit after tax Rs m4,4543,870 115.1%  
Gross profit margin %19.227.6 69.7%  
Effective tax rate %36.324.8 146.6%   
Net profit margin %14.218.8 75.6%  
BALANCE SHEET DATA
Current assets Rs m20,06111,812 169.8%   
Current liabilities Rs m14,5433,776 385.1%   
Net working cap to sales %17.639.1 45.1%  
Current ratio x1.43.1 44.1%  
Inventory Days Days5777 73.4%  
Debtors Days Days1482 17.2%  
Net fixed assets Rs m14,34314,398 99.6%   
Share capital Rs m1,694175 965.8%   
"Free" reserves Rs m19,70422,277 88.5%   
Net worth Rs m21,39822,452 95.3%   
Long term debt Rs m27 30.3%   
Total assets Rs m39,11326,962 145.1%  
Interest coverage x1,091.0444.3 245.5%   
Debt to equity ratio x00 31.8%  
Sales to assets ratio x0.80.8 104.9%   
Return on assets %11.414.4 79.2%  
Return on equity %20.817.2 120.8%  
Return on capital %31.923.0 139.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53410,682 5.0%   
Fx outflow Rs m7,0912,102 337.4%   
Net fx Rs m-6,5578,580 -76.4%   
CASH FLOW
From Operations Rs m3,9943,748 106.6%  
From Investments Rs m-1,433-2,228 64.3%  
From Financial Activity Rs m-3,584-1,475 243.0%  
Net Cashflow Rs m-1,02345 -2,263.7%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 1.6 658.1%  
FIIs % 23.8 7.6 313.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 15.4 17.0 90.6%  
Shareholders   102,036 20,968 486.6%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SHASUN PHARMA  DR. REDDYS LAB  ABBOTT INDIA  ALEMBIC  PROCTER & GAMBLE HEALTH  

Compare GSK PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


May 17, 2021 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS